Discover investment opportunities in Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $3 using our Smart AI Filter.
7 stocks found for "Stocks Under $3"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.40 Risk measure | ±59.3% Price volatility | -45.5 Valuation | 0.00% Annual yield | |||
1.55 Risk measure | ±100.0% Price volatility | -1.8 Valuation | 0.00% Annual yield | |||
0.44 Risk measure | ±100.0% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
0.33 Risk measure | ±93.8% Price volatility | 93.2 Valuation | 0.00% Annual yield | |||
1.19 Risk measure | ±88.4% Price volatility | -5.2 Valuation | 0.00% Annual yield | |||
0.81 Risk measure | ±100.0% Price volatility | -0.6 Valuation | 0.00% Annual yield | |||
1.17 Risk measure | ±75.5% Price volatility | -5.0 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
The FDA has notified Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) that it may proceed with Phase 3 trial of its lead candidate, brilaroxazine, a serotonin and dopamine receptor modulator for schizophrenia. The FDA has also signed off an additional Phase 3 trial focused on the long-term safety of brilaroxazine in patients with schizophrenia.
Read moreQ: What sectors are the stocks OSTX and BTM primarily involved in?
A: OSTX predominantly operates in the healthcare sector, focusing on biopharmaceuticals, while BTM is primarily involved in technology, offering solutions in digital media and streaming.
Q: How does the current market cap of DNN potentially impact its investment appeal?
A: DNN's relatively small market cap may suggest higher growth potential but also indicates speculative risk. Its valuation reflects market sentiment on its performance in the uranium sector.
Q: Are any of the stocks under $3 known for their dividend payouts?
A: Stocks under $3 such as these generally do not prioritize dividends, focusing instead on growth and capital appreciation. Investors interested in dividends might consider stocks in more mature industries.
Q: What economic conditions could favor an investment in RVPH?
A: RVPH may perform better in economic environments favoring pharmaceutical innovation and healthcare spending increases. Its corrections from regulatory changes in health policies will be key.
Q: Could SDST stocks offer stability during volatile market conditions?
A: Given its position as a smaller-cap stock, SDST may experience higher volatility compared to large-cap stocks, which could reduce its stability in turbulent markets.
Q: How does geographical location influence CRDL's market strategy?
A: CRDL's operations, depending on their geographic focus, can be influenced by local market demand, access to raw materials, and regional regulatory changes, impacting its competitive position.